Clinical Trial Update: Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis [Phase 2]

View source ↗

Summary

A Phase 2a trial of Alpibectir plus Ethionamide for tuberculous meningitis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculous Meningitis

Drugs mentioned

• Alpibectir
• Ethionamide (ethionamide)

Snippet

Sponsor: BioVersys AG | Conditions: Tuberculosis Meningitis | Phase 2 | Status: NOT_YET_RECRUITING